NCT01567358View on ClinicalTrials.gov

Study of NI-071 in Comparison With Remicade in Patients With Rheumatoid Arthritis

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

April 30, 2013

Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL

Infliximab

100mg/vial

BIOLOGICAL

Infliximab

100mg/vial

Trial Locations (1)

982-0032

392001001, Sendai

Sponsors
All Listed Sponsors
lead

Nichi-Iko Pharmaceutical Co., Ltd.

INDUSTRY

NCT01567358 - Study of NI-071 in Comparison With Remicade in Patients With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter